| 2,673 | 27 | 116 |
| 下载次数 | 被引频次 | 阅读次数 |
目的:从多成分网络药理学及动力学研究现状探讨中药复方网络药理学及其动力学关键技术问题的研究方法。方法:分析中医药学科与网络药理学科研究的特点,根据中药复方药效物质作用的本源,结合中药现代化的要求,提出中药复方网络药理学研究的总体思路与方法。结果:与单成分有效性研究相比,中药复方的网络药理学问题分静态与动态两种形式,静态是指中药复方入口前的原成分群与某一时间点固定的网络关系,如中药复方采用指纹图谱表达,亦为网络谱效学问题;动态的网络药理学问题是指入口后中药动态代谢后血样中成分群与各时间点的网络药效动力学问题,与指纹图谱结合后者为网络谱效动力学,后者包括前者,因此中药复方网络谱效动力学问题是量-比、量-时、量-效三者的有机统一整体;结论:中药复方的网络药理学的关键而又基础的科学问题是基于网络平衡常数表征的网络谱效动力学参数测算问题。
Abstract：Aim:To investigate the research method how to study the key problems of network pharmacology and pharmacodynamics for Chinese Materia Medica Formula with a view on situation of that for multiple ingredients.Methods:to analyze the research characteristics of network pharmacology and CMM's discipline,according to the effective mechanism of constitutes in CMM's formula,combining the requirements of modernization of CMM,finally It was illuminated the modernization thoughts and methods on investigating network pharmacology and pharmacodynamics of the CMM's formula.Results:The CMM's fomula network pharmacology,comparison with the single ingredient,was considered as two forms,the static and dynamic.The static form meant the network topologic relationship of original ingredients before oral administration,whereas the dynamic form did the network pharmacodynamic relationship of metabolic ingredients in blood at any time after oral administration.If the ingredients in CMM's fomula were determined by chromatographic fingerprint,The static form was called as network pharmacy metrology with chromatographic fingerprint(NPMCF) for CMM's fomula while the dynamic as network pharmacodynamics with chromatographic fingerprint(NPDCF) for CMM's fomula that suggested the NPMCF was included in NPDCF.The NPDCF's problems of CMM's formula is represented integrally to three variation relationship as dose-ratios,dose-chrono and dose-effect.Conclusion:The key basic problems for CMM's fomula network pharmacology is how to determine parameters of NPDFC represented by network equilibrium constants.
1 Hopkins AL.Network pharmacology.Nat Biotechno1,2007;25(10)∶1110～1111
2 Hopkins AL.Network pharmacology:the next paradigm in drug discover-y.Nat Chem bio1,2008;4(11)∶682～690
3贺福元,邓凯文,刘文龙,等.中药与人体的作用本质"网通虹势"的多重遗传谱效动力学.中国实验方剂学杂志,2011;17(2)∶240～247
4 Trey Ideker and Roded Sharan.Protein networks in disease.Genome Res.2008;18∶644～652
5王娟,李学军.网络药理学与药物发现研究进展.生理科学进展,2011;42(4)∶241～245
6赵静,张卫东.基于系统生物学的多靶点及多组分药物研究的进展.中国药学杂志,2010;45(15)∶1121～1126
7贺福元,周宏灏,罗杰英.多成分药物动力学代谢网络动力学数学模型建立及参数分析.中国临床药理学与治疗学,2007;12(12)∶1321～1330
8邱云,贺福元,龚力民,等.鱼腥草及新鱼腥草素钠注射剂在大鼠体内的"网通性"代谢规律研究中药材,2010;33(9)∶1428～143
9 Limin Li,Xiaobo Zhou,Waiki Ching,et al.Predicting enzyme targets for cancer drugs by profiling human metabolic reactions in NCI-60 cell lines.BMC Bioinformatics,2010;11∶501～507
10 Selvarasu S,Kimdo Y,Karimi IA,et al.Combined data preprocessing and multivariate statistical analysis characterizes fed-batch culture of mouse hybridoma cells for rational medium design.J Biotechnol,2010;150(1)∶94～100
11 McArdle A,Kruger U,Hahn J.Multivariate statistical analysis applied to an IL6 signal transduction model in hepatocytes.Stat Med,2009;28(19)∶2401～2434
12 Zikai Wu,Xingming Zhao,Luonan Chen.A systems biology approach to identify effective cocktail drugs.BMC Systems Biology,2010;4(Suppl 2)∶S7
13 Zhao S,Li S.Network-based relating pharmacological and genomic spaces for drug target identification.PLoS One,2010;5(7)∶e11764
14 Berger SI,Iyengar R.Network analyses in systems pharmacology.Bioinformatics.2009 Oct 1;25(19)∶2466-72.Epub 2009 Jul 30
15 Li S,Zhang B,Zhang N.Network target for screening synergistic drug combinations with application to traditional Chinese medicine.BMC Syst Bi-ol,2011;5 Suppl 1∶S10
16黄海滨,邵平.基于拓扑结构的生物网络关键节点识别研究进展.玉林师范学院学报(自然科学),2009;30(3)∶6～10
17马瑞新,邓贵仕,闫兆法,等.基于动量粒子群优化的社会网络分析.郑州大学学报(理学版),2011;43(2)∶38～42
18 Ma'ayan A.Network integration and graph analysis in mammalian molec-ular systems biology.IET Syst Biol,2008;2(5)∶206～221
19 Fang K,Zhao H,Sun C,etal.Exploring the metabolic network of the epidemic pathogen Burkholderia cenocepacia J2315 via genome-scale recon-struction.BMC Syst Biol,2011;5∶83
20 Chang RL,Xie L,Xie L,et al.Drug off-target effects predicted using structural analysis in the context of a metabolic network model.PLoS Comput Biol,2010;6(9)∶e1000938
21 Imming P,Sinning C,Meyer A.Drugs,their targets and the nature and number of drug targets.Nat Rev Drug Discov,2006;5(10)∶821～834
22 Takigawa I,Tsuda K,Mamitsuka H.Mining significant substructure pairs for interpreting polypharmacology in drug-target network.PLoS One,2011;6(2)∶e16999
23夏强,钱令波.心脑缺血再灌注损伤的机制及防治策略研究进展.浙江大学学报(医学版),2010;39(6)∶38～45
24陆君安,吕金虎,刘慧,等.复杂动力网络结构识别的某些新进展.复杂系统与复杂性科学,2010;(2)∶63～69
25官山,朱陈平,刘宗华,等.复杂网络动力学框架的几个研究方向.复杂系统与复杂性科学,2008;5(3)∶9～18
26严诗楷,赵静,窦圣姗.基于系统生物学与网络生物学的现代中药复方研究体系.中国天然药物,2009;7(4)∶249～259
27孙端元,郑青山,主编.数学药理学新论.北京∶人民卫生出版社,第1版2004∶188～210
28 Imming P,Sinning C,Meyer A.Drugs,their targets and the nature and number of drug targets.Nat Rev Drug Discov,2006;5(10)∶821～834
29 Ruschak AM,Kay LE.Methyl groups as probes of supra-molecular structure,dynamics and function.J Biomol NMR,2010;46(1)∶75～87
30袁亚湘,孙文瑜,编.最优化理论与方法.北京∶科学出版社,第2版,1999∶46～54
31蒋慧娟,陈亮,孙洋,等.酶联免疫吸附法测定血浆中芍药苷浓度.分析化学,2008;36(9)∶1238～1240
32蔡碧双,邵幼岩,林纪昀,等.甘草酸人工抗原的合成鉴定及免疫原性分析.中国生化药物杂,2008;29(1)∶19～22
33李赞忠,乔子荣.现代仪器分析技术的新进展.内蒙古石油化工,2010;20(23)∶69～70
34王宇,沈玉栋,雷红涛,等.免疫分析标记技术研究进展.食品工业科技,2007;28(10)∶221～225
35马正飞,殷翔编著.数学计算方法与软件的工程应用.北京∶化学工业出版社,2002∶13～20
36 James Wei and Charles D.Prater The structure and analysis of complex reaction systems in the book written by W.G.Frankenburg∶ADVANCES IN CATALYSIS AND RELATED SUBJECTS,New york:Academic Press INC.1962 Volume 13∶203
37李梢.基于生物网络调控的方剂研究模式与实践.中西医结合学报,2007;5(5)∶489～493
38高燕燕,孙金峤,沙彬.等.新生大鼠脑缺血后脑室下区基因表达谱的生物信息学分析.中国循证儿科杂志,2008;3(5)∶374～380
39贺福元,邓凯文,石继连,刘文龙,刘平安,周宏灏.中药及复方药效动力学:谱效动学数学模型的建立及对鱼腥草注射剂的研究.现代化中药制剂发展与中药药理学研究交流会论文集,2009∶16～37
基本信息:
DOI：10.13412/j.cnki.zyyl.2012.05.071
中图分类号:R285
引用信息:
[1]贺福元,邓凯文,刘文龙,等.中药复方网络药理学及其动力学关键技术问题的探讨[J].中药药理与临床,2012,28(05):256-259+17.DOI:10.13412/j.cnki.zyyl.2012.05.071.
基金信息:
湖南省自然基金重点(11JJ2055);; 教育厅重点(09A068)资助资助
2012-10-15
2012-10-15